[Epidemiologic study of anti-HCV antibodies in Tunisian blood donors].
A study carried out on 2,006 Tunisian blood donors permitted us to evaluate the prevalence of hepatitis C virus antibodies (anti-HCV) which was 1.09%; frequency of indirect markers of NANBH were as follows: ALAT greater than 2 N (1.24%), anti-HBc (30.35%), 55.5% of HCV (+) donors had anti-HBc (+), 12.5% had rises ALAT and only 33.3% both markers.
Slama
H
H
Centre National de Transfusion sanguine, Tunis.
Mojaat
N
N
Dahri
R
R
Boukef
K
K
D001782:Blood Donors; D016174:Hepacivirus / Q000276:immunology*; D006508:Hepatitis Antibodies / Q000032:analysis*; D006526:Hepatitis C / Q000453:epidemiology*; D006801:Humans; D014416:Tunisia / Q000208:ethnology
D006508:Hepatitis Antibodies
Etude épidémiologique des anticorps anti-HCV chez les donneurs de sang en Tunisie.